Using surface plasmon resonance spectroscopy to characterize the inhibition of NGF-p75(NTR) and proNGF-p75(NTR) interactions by small molecule inhibitors

Nerve growth factor (NGF), a member of the neurotrophin family, acts to influence the survival and differentiation of neurons in both the central and peripheral nervous systems via its binding to the p75(NTR) and TrkA receptors. Its precursor, proNGF, has been shown to be the dominant form of NGF in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacological research 2016-01, Vol.103, p.292-299
Hauptverfasser: Sheffield, Kristen S A, Vohra, Rahul, Scott, John A, Ross, Gregory M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 299
container_issue
container_start_page 292
container_title Pharmacological research
container_volume 103
creator Sheffield, Kristen S A
Vohra, Rahul
Scott, John A
Ross, Gregory M
description Nerve growth factor (NGF), a member of the neurotrophin family, acts to influence the survival and differentiation of neurons in both the central and peripheral nervous systems via its binding to the p75(NTR) and TrkA receptors. Its precursor, proNGF, has been shown to be the dominant form of NGF in the central nervous system, suggesting a biological function beyond its role as a precursor. Like NGF, proNGF is known to bind the p75(NTR) receptor. The dysregulation of both NGF and proNGF have been implicated in several pathologies, including neurodegenerative diseases linked to p75(NTR)-mediated apoptotic signaling. Therefore, the identification of small molecule inhibitors capable of inhibiting both NGF and proNGF-p75(NTR) interactions may be of therapeutic interest. In the present study, we examine the inhibitory action of known small molecule-based inhibitors PD90780, ALE-0540, Ro 08-2750, and PQC 083, as well as novel derivatives of these compounds, using surface plasmon resonance (SPR) spectroscopy.
doi_str_mv 10.1016/j.phrs.2015.12.005
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1762347561</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1762347561</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-c5c8130afece72e7cb05330adb54f8ce18caa866c968f5e7ba99c0fd1226cebe3</originalsourceid><addsrcrecordid>eNpVkE1Lw0AQhhdBbK3-AQ-yx3pI3Em6m-QoxVahVJD2HDabid2S7Mbd5FD_if_WBT_A0zAvz_swDCE3wGJgIO6PcX9wPk4Y8BiSmDF-RqbAChEB5GJCLr0_MsaKBbALMkmEyHgGYko-916bN-pH10iFtG-l76yhDr010oTE96gGZ72y_YkOlqqDdFIN6PQH0uGAVJuDrvSgQ8s2dLteRX3G59vd6x2Vpqa9s_8ybUI3CALvaXWivpNtSzvbohrbP5t1_oqcN7L1eP0zZ2S_etwtn6LNy_p5-bCJ-gRgiBRXOaRMNqgwSzBTFeNp2OuKL5pcIeRKylwIVYi84ZhVsigUa2pIEqGwwnRG5t_ecOn7iH4oO-0Vtq00aEdfQiaSdJFxAQG9_UHHqsO67J3upDuVv-9MvwDc8XlK</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1762347561</pqid></control><display><type>article</type><title>Using surface plasmon resonance spectroscopy to characterize the inhibition of NGF-p75(NTR) and proNGF-p75(NTR) interactions by small molecule inhibitors</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Sheffield, Kristen S A ; Vohra, Rahul ; Scott, John A ; Ross, Gregory M</creator><creatorcontrib>Sheffield, Kristen S A ; Vohra, Rahul ; Scott, John A ; Ross, Gregory M</creatorcontrib><description>Nerve growth factor (NGF), a member of the neurotrophin family, acts to influence the survival and differentiation of neurons in both the central and peripheral nervous systems via its binding to the p75(NTR) and TrkA receptors. Its precursor, proNGF, has been shown to be the dominant form of NGF in the central nervous system, suggesting a biological function beyond its role as a precursor. Like NGF, proNGF is known to bind the p75(NTR) receptor. The dysregulation of both NGF and proNGF have been implicated in several pathologies, including neurodegenerative diseases linked to p75(NTR)-mediated apoptotic signaling. Therefore, the identification of small molecule inhibitors capable of inhibiting both NGF and proNGF-p75(NTR) interactions may be of therapeutic interest. In the present study, we examine the inhibitory action of known small molecule-based inhibitors PD90780, ALE-0540, Ro 08-2750, and PQC 083, as well as novel derivatives of these compounds, using surface plasmon resonance (SPR) spectroscopy.</description><identifier>EISSN: 1096-1186</identifier><identifier>DOI: 10.1016/j.phrs.2015.12.005</identifier><identifier>PMID: 26675716</identifier><language>eng</language><publisher>Netherlands</publisher><subject>Heterocyclic Compounds, 3-Ring - pharmacology ; Nerve Growth Factor - antagonists &amp; inhibitors ; Nerve Growth Factor - metabolism ; Pteridines - pharmacology ; Quinazolines - pharmacology ; Receptor, Nerve Growth Factor - metabolism ; Surface Plasmon Resonance</subject><ispartof>Pharmacological research, 2016-01, Vol.103, p.292-299</ispartof><rights>Copyright © 2015 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26675716$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sheffield, Kristen S A</creatorcontrib><creatorcontrib>Vohra, Rahul</creatorcontrib><creatorcontrib>Scott, John A</creatorcontrib><creatorcontrib>Ross, Gregory M</creatorcontrib><title>Using surface plasmon resonance spectroscopy to characterize the inhibition of NGF-p75(NTR) and proNGF-p75(NTR) interactions by small molecule inhibitors</title><title>Pharmacological research</title><addtitle>Pharmacol Res</addtitle><description>Nerve growth factor (NGF), a member of the neurotrophin family, acts to influence the survival and differentiation of neurons in both the central and peripheral nervous systems via its binding to the p75(NTR) and TrkA receptors. Its precursor, proNGF, has been shown to be the dominant form of NGF in the central nervous system, suggesting a biological function beyond its role as a precursor. Like NGF, proNGF is known to bind the p75(NTR) receptor. The dysregulation of both NGF and proNGF have been implicated in several pathologies, including neurodegenerative diseases linked to p75(NTR)-mediated apoptotic signaling. Therefore, the identification of small molecule inhibitors capable of inhibiting both NGF and proNGF-p75(NTR) interactions may be of therapeutic interest. In the present study, we examine the inhibitory action of known small molecule-based inhibitors PD90780, ALE-0540, Ro 08-2750, and PQC 083, as well as novel derivatives of these compounds, using surface plasmon resonance (SPR) spectroscopy.</description><subject>Heterocyclic Compounds, 3-Ring - pharmacology</subject><subject>Nerve Growth Factor - antagonists &amp; inhibitors</subject><subject>Nerve Growth Factor - metabolism</subject><subject>Pteridines - pharmacology</subject><subject>Quinazolines - pharmacology</subject><subject>Receptor, Nerve Growth Factor - metabolism</subject><subject>Surface Plasmon Resonance</subject><issn>1096-1186</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkE1Lw0AQhhdBbK3-AQ-yx3pI3Em6m-QoxVahVJD2HDabid2S7Mbd5FD_if_WBT_A0zAvz_swDCE3wGJgIO6PcX9wPk4Y8BiSmDF-RqbAChEB5GJCLr0_MsaKBbALMkmEyHgGYko-916bN-pH10iFtG-l76yhDr010oTE96gGZ72y_YkOlqqDdFIN6PQH0uGAVJuDrvSgQ8s2dLteRX3G59vd6x2Vpqa9s_8ybUI3CALvaXWivpNtSzvbohrbP5t1_oqcN7L1eP0zZ2S_etwtn6LNy_p5-bCJ-gRgiBRXOaRMNqgwSzBTFeNp2OuKL5pcIeRKylwIVYi84ZhVsigUa2pIEqGwwnRG5t_ecOn7iH4oO-0Vtq00aEdfQiaSdJFxAQG9_UHHqsO67J3upDuVv-9MvwDc8XlK</recordid><startdate>201601</startdate><enddate>201601</enddate><creator>Sheffield, Kristen S A</creator><creator>Vohra, Rahul</creator><creator>Scott, John A</creator><creator>Ross, Gregory M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201601</creationdate><title>Using surface plasmon resonance spectroscopy to characterize the inhibition of NGF-p75(NTR) and proNGF-p75(NTR) interactions by small molecule inhibitors</title><author>Sheffield, Kristen S A ; Vohra, Rahul ; Scott, John A ; Ross, Gregory M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-c5c8130afece72e7cb05330adb54f8ce18caa866c968f5e7ba99c0fd1226cebe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Heterocyclic Compounds, 3-Ring - pharmacology</topic><topic>Nerve Growth Factor - antagonists &amp; inhibitors</topic><topic>Nerve Growth Factor - metabolism</topic><topic>Pteridines - pharmacology</topic><topic>Quinazolines - pharmacology</topic><topic>Receptor, Nerve Growth Factor - metabolism</topic><topic>Surface Plasmon Resonance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sheffield, Kristen S A</creatorcontrib><creatorcontrib>Vohra, Rahul</creatorcontrib><creatorcontrib>Scott, John A</creatorcontrib><creatorcontrib>Ross, Gregory M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacological research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sheffield, Kristen S A</au><au>Vohra, Rahul</au><au>Scott, John A</au><au>Ross, Gregory M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Using surface plasmon resonance spectroscopy to characterize the inhibition of NGF-p75(NTR) and proNGF-p75(NTR) interactions by small molecule inhibitors</atitle><jtitle>Pharmacological research</jtitle><addtitle>Pharmacol Res</addtitle><date>2016-01</date><risdate>2016</risdate><volume>103</volume><spage>292</spage><epage>299</epage><pages>292-299</pages><eissn>1096-1186</eissn><abstract>Nerve growth factor (NGF), a member of the neurotrophin family, acts to influence the survival and differentiation of neurons in both the central and peripheral nervous systems via its binding to the p75(NTR) and TrkA receptors. Its precursor, proNGF, has been shown to be the dominant form of NGF in the central nervous system, suggesting a biological function beyond its role as a precursor. Like NGF, proNGF is known to bind the p75(NTR) receptor. The dysregulation of both NGF and proNGF have been implicated in several pathologies, including neurodegenerative diseases linked to p75(NTR)-mediated apoptotic signaling. Therefore, the identification of small molecule inhibitors capable of inhibiting both NGF and proNGF-p75(NTR) interactions may be of therapeutic interest. In the present study, we examine the inhibitory action of known small molecule-based inhibitors PD90780, ALE-0540, Ro 08-2750, and PQC 083, as well as novel derivatives of these compounds, using surface plasmon resonance (SPR) spectroscopy.</abstract><cop>Netherlands</cop><pmid>26675716</pmid><doi>10.1016/j.phrs.2015.12.005</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier EISSN: 1096-1186
ispartof Pharmacological research, 2016-01, Vol.103, p.292-299
issn 1096-1186
language eng
recordid cdi_proquest_miscellaneous_1762347561
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Heterocyclic Compounds, 3-Ring - pharmacology
Nerve Growth Factor - antagonists & inhibitors
Nerve Growth Factor - metabolism
Pteridines - pharmacology
Quinazolines - pharmacology
Receptor, Nerve Growth Factor - metabolism
Surface Plasmon Resonance
title Using surface plasmon resonance spectroscopy to characterize the inhibition of NGF-p75(NTR) and proNGF-p75(NTR) interactions by small molecule inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T06%3A43%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Using%20surface%20plasmon%20resonance%20spectroscopy%20to%20characterize%20the%20inhibition%20of%20NGF-p75(NTR)%20and%20proNGF-p75(NTR)%20interactions%20by%20small%20molecule%20inhibitors&rft.jtitle=Pharmacological%20research&rft.au=Sheffield,%20Kristen%20S%20A&rft.date=2016-01&rft.volume=103&rft.spage=292&rft.epage=299&rft.pages=292-299&rft.eissn=1096-1186&rft_id=info:doi/10.1016/j.phrs.2015.12.005&rft_dat=%3Cproquest_pubme%3E1762347561%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1762347561&rft_id=info:pmid/26675716&rfr_iscdi=true